Explore more publications!
Cincinnati Wellness Review
Got News to Share?

Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 12, 2025

Lessing’s Hospitality Group Partners with Catholic Health to Launch Shoreline Café Across Long Island Hospitals
December 12, 2025

Lessing’s Hospitality Group Partners with Catholic Health to Launch Shoreline Café Across Long Island Hospitals

Indeterminate GlobeNewswire
Anavar Steroid 2026: Legal Steroid Alternative, Anavar For Women Cycle, Dosage, Side Effects, Anavar Before And After Result (Anavar for Sale) Launch Alternative Anvarol By CrazyBulk
December 12, 2025

Anavar Steroid 2026: Legal Steroid Alternative, Anavar For Women Cycle, Dosage, Side Effects, Anavar Before And After Result (Anavar for Sale) Launch Alternative Anvarol By CrazyBulk

Indeterminate GlobeNewswire
Cullgen Reports Positive Results from Phase 1 Study of its Novel Non-Opioid Product Candidate CG001419 for Pain
December 12, 2025

Cullgen Reports Positive Results from Phase 1 Study of its Novel Non-Opioid Product Candidate CG001419 for Pain

Indeterminate GlobeNewswire
Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment
December 12, 2025

Clearmind Medicine's MEAI Spotlighted in Prestigious Review: Leading Experts Affirm Transformative Potential for Alcohol Use Disorder Treatment

Indeterminate GlobeNewswire
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
December 12, 2025

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site

Indeterminate GlobeNewswire
RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.
December 12, 2025

RadioMedix Expands Thorium-228 Supply Network Through New Agreement With Van Overeem Nuclear B.V.

Indeterminate GlobeNewswire
Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure
December 12, 2025

Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure

Indeterminate GlobeNewswire
Novartis breaks ground on flagship manufacturing hub in North Carolina
December 12, 2025

Novartis breaks ground on flagship manufacturing hub in North Carolina

Indeterminate GlobeNewswire
Option Care Health to Participate in the J.P. Morgan Healthcare Conference
December 12, 2025

Option Care Health to Participate in the J.P. Morgan Healthcare Conference

Indeterminate GlobeNewswire
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path
December 12, 2025

BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asian Subset for EGFR WT NSCLC Compared to Docetaxel, Strengthening the Case for a Global Registration Path

Indeterminate GlobeNewswire
Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer
December 12, 2025

Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer

Indeterminate GlobeNewswire
Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025
December 12, 2025

Relay Therapeutics Announces Efficacy Subset Analysis of Zovegalisib (RLY-2608) + Fulvestrant in Breast Cancer Patients Pre-Treated with SERD or with ESR1 Mutations at SABCS 2025

Indeterminate GlobeNewswire
Nova Leap Health Corp. Grants Stock Options
December 12, 2025

Nova Leap Health Corp. Grants Stock Options

Indeterminate GlobeNewswire
Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025
December 12, 2025

Revuforj® (revumenib) Named Best New Drug at the Scrip Awards 2025

Indeterminate GlobeNewswire
Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
December 12, 2025

Clearmind Medicine Successfully Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Indeterminate GlobeNewswire
Tenaya Therapeutics Announces Pricing of Public Offering
December 12, 2025

Tenaya Therapeutics Announces Pricing of Public Offering

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions